Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that signals your brain to eat less and feel fuller longer—a mechanism backed by trials showing average weight loss of 15% or more over 68 weeks. Understanding how this injectable medication works, how to use it properly, and what results to expect can help you make an informed decision about whether it's right for your weight loss goals.
How Semaglutide Injections Work in Your Body
Semaglutide activates GLP-1 receptors in areas of your brain that control hunger and satiety, reducing the drive to eat and increasing feelings of fullness after smaller meals. The medication also slows stomach emptying, meaning food stays in your digestive system longer, which extends the sensation of satisfaction between meals. Additionally, semaglutide helps stabilize blood sugar levels by stimulating insulin release when glucose rises, which can reduce energy crashes and cravings that often trigger overeating.
The biological effect typically begins within hours of injection, though peak appetite suppression is usually noticed within 2–5 days as the medication accumulates in your system. Your body gradually becomes accustomed to the GLP-1 signal, which is why dose increases may be needed over time—a common part of personalized weight loss protocols. PlexusDx offers compounded semaglutide through licensed 503A pharmacies, allowing your provider to adjust dosing based on your individual response and tolerance.
Semaglutide Injection Dosing and Administration Schedule
Semaglutide is administered as a once-weekly subcutaneous injection, typically given in the abdomen, thigh, or upper arm—areas with enough subcutaneous tissue for comfortable injection. Most patients start at a low dose (0.25 mg) and gradually increase every 2–4 weeks, reaching therapeutic doses of 1.0–2.4 mg per week depending on clinical goals and individual tolerance. This gradual escalation approach minimizes gastrointestinal side effects and allows your body to adapt to the medication's hunger-suppressing effects.
You can self-administer the injection using a simple pen device at home after brief training from your healthcare provider or clinic staff. The injection takes less than 10 seconds, and most patients report minimal to no pain due to the small needle gauge. PlexusDx coordinates with your provider to ensure you receive clear injection training, written instructions, and ongoing support to help you stay consistent with your weekly dosing schedule.
Expected Weight Loss Results and Timeline
Weight loss typically begins within 2–4 weeks of starting semaglutide, with most patients experiencing noticeable appetite suppression even at lower doses. Clinical trials demonstrate that by week 16–20 of treatment, patients average 5–10% body weight reduction, and by week 68, average reductions reach 15% or higher when combined with lifestyle modifications like modest calorie reduction and increased physical activity. Individual results vary widely based on genetics, baseline metabolic rate, adherence to healthy habits, and dose tolerance.
Consistency matters more than rapid increases—patients who gradually build tolerance to higher doses and maintain steady injection schedules typically see more sustained weight loss than those who skip doses or reduce frequency. Many patients continue losing weight for several months after reaching their target dose, with losses often stabilizing between months 4–6 of consistent treatment. PlexusDx providers monitor your progress through regular check-ins and may recommend the Precision Peptide Genetic Test to understand your individual peptide-pathway response and optimize your personalized treatment plan.
Common Side Effects and How to Manage Them
Nausea is the most frequently reported side effect, especially during the first 1–3 weeks or after dose increases, but it typically diminishes as your body adjusts. Mild to moderate gastrointestinal effects—such as constipation, loose stools, or reduced appetite for previously favorite foods—are common and usually manageable through dietary adjustments like increased fiber, hydration, and eating smaller, protein-rich meals. These symptoms are temporary in most cases and are not dangerous, though any severe or persistent side effects should be reported to your healthcare provider immediately.
Serious side effects are rare but can include pancreatitis (severe abdominal pain), gallbladder issues, or allergic reactions—none of which are expected in the typical patient population. Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia. PlexusDx providers conduct a thorough medical screening before prescribing to identify contraindications and ensure semaglutide is a safe choice for your health profile.
Why Semaglutide Pricing Remains Flat Regardless of Your Dose
PlexusDx offers compounded semaglutide injections starting at $149 per month, with your price staying the same whether your dose increases from 0.25 mg to 2.4 mg over time. This flat-rate model removes financial uncertainty—your dose may need to go up, but your price won't—making it easier to follow your prescribed escalation schedule without worrying about escalating out-of-pocket costs. No insurance is required, and the medication is HSA/FSA eligible, offering additional savings flexibility.
All PlexusDx medications are compounded by licensed 503A pharmacies, which means they're customized for safety and quality under strict federal oversight, and shipped directly to your home across all 50 states. There are no membership fees or hidden charges—just transparent, affordable access to personalized weight loss therapy. After your first month of treatment, you also have the option to add the Precision Peptide Genetic Test ($99) to map your unique peptide pathways and fine-tune your medication strategy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I see weight loss results from semaglutide injections?
Most patients notice appetite suppression within 2–5 days of their first injection, with measurable weight loss typically appearing within 2–4 weeks. Significant reductions (5–10% body weight) are common by week 16–20 of consistent treatment. PlexusDx providers monitor your progress and adjust dosing to keep you on track toward your personalized goals.
Can I stop semaglutide injections once I reach my weight loss goal?
Semaglutide is designed as an ongoing treatment, not a short-term intervention—weight may return if the medication is discontinued without long-term lifestyle maintenance. Your PlexusDx provider will discuss duration of treatment, maintenance dosing, and strategies to sustain your results through continued healthy habits and medication compliance.
How much does PlexusDx compounded semaglutide cost, and do I need insurance?
PlexusDx compounded semaglutide injections start at $149 per month with no insurance required, no membership fees, and HSA/FSA eligibility. Your flat monthly price covers all dose levels—your dose may increase, but your cost remains the same, simplifying your weight loss investment.
What should I do if I experience nausea or other side effects?
Mild nausea and GI effects are common during the first 1–3 weeks and typically resolve with dietary adjustments (smaller meals, increased hydration, more protein) and time. Contact your PlexusDx provider immediately if you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction—these rare events require prompt medical attention.
How can the Precision Peptide Genetic Test help optimize my semaglutide therapy?
The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes 14 peptide pathways and 150+ genetic insights, including your GLP1R and GIPR variants, to predict how your body responds to GLP-1 therapy. This personalization helps your provider adjust your treatment plan and medication choice to maximize your weight loss and minimize side effects.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Nutrition: What Happens If You Don’t Eat Enough on Wegovy
Navigating Your Treatment: How Many Pens in an Ozempic Box and What It Means for Your Health Journey